Meril Life Sciences Pvt. Ltd

EVERMINE50

Breakthrough in DES Technology:

• Ultra-low strut thickness of 50μm for promoting early vascular healing
• Variable strut width and variable crown design to ensure adequate radial strength of 1.1bar*
• Hybrid cell stent design: Open cells in the middle of the stent for side-branch access and closed cell design on ends for optimal scaffolding and conformability
• Clinically established drug everolimus with biodegradable polymer for proven clinical safety &long term efficacy